Corporate News     21-May-24 Board of Jagsonpal Pharmaceuticals recommends final dividend Of Rs 5 per share Jagsonpal Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 20 May 2024, inter alia, have recommended the final dividend of Rs 5 per equity Share (i.e. 100%) , subject to the approval of the shareholders. Previous News   Jagsonpal Pharmaceuticals to conduct board meeting  ( Corporate News - 24-May-22   11:37 )   Jagsonpal Pharmaceuticals standalone net profit declines 47.81% in the March 2020 quarter  ( Results - Announcements 29-Jul-20   15:13 )   Jagsonpal Pharmaceuticals to conduct board meeting  ( Corporate News - 16-May-23   15:29 )   Jagsonpal Pharmaceuticals grants 4.70 lakh stock options  ( Corporate News - 29-Aug-22   18:26 )   Jagsonpal Pharmaceuticals standalone net profit declines 96.63% in the December 2014 quarter  ( Results - Announcements 13-Feb-15   15:47 )   Jagsonpal Pharmaceuticals standalone net profit rises 26.00% in the June 2020 quarter  ( Results - Announcements 29-Jul-20   15:40 )   Jagsonpal Pharmaceuticals standalone net profit rises 97.54% in the September 2020 quarter  ( Results - Announcements 10-Nov-20   15:25 )   Jagsonpal Pharmaceuticals to convene EGM  ( Corporate News - 24-May-22   10:41 )   Jagsonpal Pharmaceuticals standalone net profit rises 173.97% in the June 2019 quarter  ( Results - Announcements 17-Aug-19   12:37 )   Jagsonpal Pharmaceuticals standalone net profit rises 18.92% in the September 2015 quarter  ( Results - Announcements 13-Nov-15   15:35 )   Board of Jagsonpal Pharmaceuticals recommends final dividend  ( Corporate News - 24-May-23   15:01 )	Other Stories   Mercury Trade Links to conduct EGM   15-Mar-25   20:06   Galada Finance to conduct board meeting   15-Mar-25   20:06   Board of Galaxy Surfactants recommends interim dividend   15-Mar-25   16:12   Heads UP Ventures announces board meeting date   15-Mar-25   16:12   Savera Industries to conduct board meeting   15-Mar-25   16:12   Strides Pharma Science announces acquisition of Singapore-based Amexel   15-Mar-25   15:45   Mphasis allots 99,115 equity shares under ESOP   15-Mar-25   15:43   Shilpa Pharma Lifesciences' Unit-2 clear USFDA inspection   15-Mar-25   15:40   Wipro grants 9,868 RSUs under ESOP   15-Mar-25   15:39   New Delhi Television announces resignation of director   15-Mar-25   15:38
Back Top